Arthritis UK launches two important reports highlighting the far-reaching impacts of arthritis and MSK conditions on patients’ lives

Arthritis UK’s The State of Musculoskeletal (MSK) Health 2025 lays bare the prevalence of arthritis and MSK conditions a
Find out more

Top keynote sessions to see at Case-based Conference 2025 in Cardiff

Case-based Conference 2025 will take place on 4–5 November 2025 at the Cardiff Marriott, Mill Lane. This two-day, in-per
Find out more

New guideline scope: Biologic and targeted synthetic DMARD safety in inflammatory arthritis

The upcoming guideline from the British Society for Rheumatology will replace the previous version from 2019 to provide up-to-date and evidence-based recommendations for the safe use of biologic and targeted synthetic DMARDs
Find out more

5 insights from the NEIAA annual report and why clinicians should use the dashboard

The National Early Inflammatory Autoimmune Diseases Audit (NEIAA) collects data on newly diagnosed patients across England, Wales and, from April 2025, Jersey. The audit measures how services are performing against NICE quality standards
Find out more

Behçets living guideline update

Just 12 months later, the latest iteration of the beçhets clinical guideline has just been co-published by BSR and the British Association of Dermatologists in both Rheumatology and the British Journal of Dermatology.
Find out more

Paracetamol use in pregnancy remains a recommended and safe option for pain relief

Paracetamol is confirmed safe in pregnancy by the MHRA. It remains the recommended first-choice pain relief for pregnant women when used as directed.
Find out more

Case-Based Conference 2025 in Cardiff: Learning objectives for every session

Case-based Conference 2025 will take place on 4–5 November 2025 at the Cardiff Marriott, Mill Lane. This in-person event
Find out more

NEIAA 2025: How National data is transforming early inflammatory arthritis care

The National Early Inflammatory Arthritis Audit is the only national programme providing oversight of how rheumatology services across England and Wales deliver care for people with EIA.
Find out more

Responding to Triamcinolone shortages

Medicine shortages are increasingly affecting patients and clinicians across rheumatology. Among the most concerning are the recent disruptions to Triamcinolone hexacetonide (TH) and Triamcinolone acetonide (TA)
Find out more

Register Champion: Anne-Marie

Introducing Anne-Marie, one of our fantastic Register Champions on the BSRBR-RA study. Based at Kettering General Hospital, Anne-Marie plays a vital role in identifying, recruiting, and supporting patients to take part in the register.
Find out more